Point72 Middle East FZE’s Idexx Laboratories IDXX Stock Holding History

Point72 Middle East FZE’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,830	Closed	-$1.57M	–	635
2023 Q4	$1.57M	Buy	+2,830	New	+$1.33M	0.05%	459
2023 Q1	–	Sell	-6,114	Closed	-$2.93M	–	1888
2022 Q4	$2.49M	Buy	+6,114	New	+$2.37M	0.11%	250

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's IDXX Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 2,830 shares — an estimated $1.57M sold.

Point72 Middle East FZE first reported a position in IDXX in Q4 2022 and held it in 2 quarters. The position peaked at $2.49M in Q4 2022. 1,148 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Point72 Middle East FZE reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 2,830 Idexx Laboratories shares in Q1 2024, an estimated $1.57M.
Point72 Middle East FZE first reported a position in Idexx Laboratories in Q4 2022 and held it in 2 quarters.
Point72 Middle East FZE's Idexx Laboratories position peaked at $2.49M in Q4 2022.
1,148 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.